(Q53935597)

22 May 2018

title

Some current thoughts on lithium carbonate in manic-depressive illness based on a double-blind comparison with chlorpromazine. (English)

1 reference

22 May 2018

author name string

Spring GK

series ordinal

1

1 reference

22 May 2018

publication date

1 September 1971

1 reference

22 May 2018

published in

Psychosomatics

1 reference

22 May 2018

volume

12

1 reference

22 May 2018

issue

5

1 reference

22 May 2018

page(s)

336-340

1 reference

22 May 2018

A Double-Blind Comparison of Lithium and Chlorpromazine in the Treatment of Manic States

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971498-4

7 January 2021

Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: An interim report

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971498-4

7 January 2021

Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971498-4

7 January 2021

Prophylactic use of lithium carbonate? More data concerning its use in manic-depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971498-4

7 January 2021

LITHIUM TREATMENT OF MANIC STATES.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971498-4

7 January 2021

Critique of Studies of Lithium Salts in the Treatment of Mania

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971498-4

7 January 2021

Carbohydrate metabolism in mania before and after lithium carbonate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971498-4

7 January 2021

Effectiveness of Lithium Carbonate in the Treatment of Manic-Depressive Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971498-4

7 January 2021

Prophylactic lithium: another therapeutic myth? An examination of the evidence to date

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971498-4

7 January 2021

The Use of Lithium in Affective Disorders: II. Prophylaxis of Depression in Chronic Recurrent Affective Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971498-4

7 January 2021

The clinical laboratory and electroencephalographic effects of lithium.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971498-4

7 January 2021

10.1016/S0033-3182(71)71498-4

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018